Close Menu
  • DRUGS
  • DISEASES
  • Treatments
  • Wellness

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Chondrosarcom

Cancer

Angiosarcoma

Cancer

Connective Tissue Cancer

Cancer
Facebook X (Twitter)
GoodMedTodayGoodMedToday
  • Demos
  • Health
  • Covid19
  • About Us
Facebook X (Twitter)
SUBSCRIBE
  • DRUGS
  • DISEASES
  • Treatments
  • Wellness
GoodMedTodayGoodMedToday
Home - Cancer - Multifocal Breast Cancer
Cancer

Multifocal Breast Cancer

Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
Share
Facebook Twitter LinkedIn Pinterest WhatsApp Email

Multifocal Breast Cancer: Causes, Symptoms, and Treatment

Multifocal breast cancer is a type of breast malignancy in which two or more tumors develop within the same quadrant of the breast and originate from the same primary lesion. This presentation carries a higher risk of lymph node involvement and distant metastasis than single-focus breast cancer, often requiring more complex diagnostic and treatment approaches, including surgery, chemotherapy, and radiotherapy.

Table of Contents

Toggle
  • Overview of Multifocal Breast Cancer
  • Symptoms of Multifocal Breast Cancer
  • When to See a Doctor
  • Causes
  • Diagnosis
  • Treatment
  • Lifestyle and Prevention

Overview of Multifocal Breast Cancer

What is Multifocal Breast Cancer?

Multifocal breast cancer refers to the presence of two or more malignant lesions arising within the same breast quadrant or region, typically stemming from a single primary tumor.

It must be differentiated from multicentric breast cancer, where multiple tumors arise independently in different quadrants of the breast.

Depending on diagnostic criteria, multifocal breast cancer accounts for 10–60% of breast cancer cases.

It is not necessarily more invasive than other subtypes; prognosis largely depends on the features of the largest primary tumor. However, multifocal disease is associated with higher recurrence and metastasis rates, potentially impacting outcomes.

Non-Invasive Breast Cancer

Also known as carcinoma in situ, this type remains confined to its original location without invasion of surrounding tissue. It has not extended beyond the epithelial lining of the ducts or lobules.

Ductal Carcinoma In Situ (DCIS): Begins within the breast ducts and is considered non-invasive. DCIS increases the likelihood of developing invasive breast cancer later.

Lobular Carcinoma In Situ (LCIS): Not considered a true cancer but reflects atypical cell changes in the lobules. According to the American Cancer Society, individuals with LCIS have a 7–12 times higher risk of developing invasive breast cancer in either breast.

Invasive Breast Cancer

This form invades nearby breast tissue and may spread to other parts of the body. Two major invasive types include:

Invasive Ductal Carcinoma (IDC): The most common type, accounting for ~80% of breast cancer diagnoses in the United States. It begins in the ducts and invades the surrounding breast tissue.

Invasive Lobular Carcinoma (ILC): Arises in the lobules and spreads into adjacent breast tissue. It represents about 10% of invasive breast cancers.

Female doctor wearing a pink ribbon educating a patient about multifocal breast cancer using a breast model
Healthcare professionals provide education and guidance to help patients understand multifocal breast cancer and its treatment options.

Symptoms of Multifocal Breast Cancer

Typical local changes include:

  • Breast swelling or lumps;
  • Skin dimpling or puckering;
  • Breast pain or tenderness;
  • Nipple inversion;
  • Redness, itchiness, flaking, or irritation of the breast skin;
  • Nipple discharge (yellowish, purulent, thick or thin fluid).

Systemic symptoms may include:

  • Persistent fatigue;
  • Bone pain (suggesting bone metastases);
  • Unexplained weight loss;
  • Nausea or loss of appetite;
  • Jaundice (if liver metastases);
  • Shortness of breath or cough;
  • Headaches or double vision.
Person wearing a pink ribbon holding a diagram of a breast to illustrate swelling, a common symptom of multifocal breast cancer
Breast swelling is a common symptom of multifocal breast cancer.

Complications

Compared to unifocal breast cancer, multifocal disease may have a higher risk of local recurrence.

A 2019 meta-analysis of 17 comparative studies and 7 case series (3,537 patients undergoing breast-conserving surgery) reported local recurrence rates ranging from 2–23% over a mean follow-up of 59.5 months—comparable to mastectomy outcomes, but further studies are needed.

Five-year relative survival rates (American Cancer Society):

  • Localized (no spread): 99%
  • Regional (spread to nearby structures or lymph nodes): 86%
  • Distant metastases: 31%
  • Overall (all stages): 91%

Prognosis depends on:

  • Age;
  • Overall health;
  • Tumor size;
  • Response to therapy;
  • Presence of metastasis.

When to See a Doctor

Seek prompt evaluation if you notice:

  • New lumps or persistent breast pain/swelling;
  • Nipple inversion or abnormal discharge (yellow, bloody, or purulent);
  • Persistent redness, flaking, or irritation;
  • Unexplained fatigue or weight loss;
  • Personal or family history of breast cancer.
Woman appearing tired and unwell, illustrating fatigue and unexplained weight loss often seen in multifocal breast cancer
Patients with multifocal breast cancer may experience fatigue and unexplained weight loss.

Causes

The exact mechanism of uncontrolled breast cell growth remains under investigation, but genetic mutations and lifestyle factors play key roles. Mutations may disrupt DNA repair signals, allowing unchecked cell proliferation:

BRCA1 and BRCA2 mutations: These genes produce proteins critical for DNA repair. Mutations lead to defective repair and abnormal cell growth. Women carrying these mutations face a lifetime breast cancer risk of 50–85% (compared to 12% in the general population). BRCA mutations also elevate ovarian cancer risk. Men with BRCA mutations are also at higher risk for breast and other cancers.

Family history: Even without BRCA mutations, risk increases if a mother, sister, or daughter developed breast cancer before age 40, if two relatives developed it before age 50, or if male relatives developed breast cancer. Multiple affected relatives or a history of both breast and ovarian cancer further elevates risk.

Illustration of a DNA double helix representing BRCA1 and BRCA2 gene mutations associated with a 50–85% increased risk of breast cancer in women
Women carrying BRCA1 or BRCA2 gene mutations have a 50–85% lifetime risk of developing breast cancer.

Risk Factors

Younger age: Multifocal breast cancer tends to be diagnosed in younger women.

Family history: Especially if multiple relatives are affected or bilateral breast cancer is present.

Genetic predisposition: BRCA1/BRCA2 and other related mutations.

Lifestyle: Alcohol use, smoking, poor diet, and prolonged hormone replacement therapy.

Medical history: Previous breast cancer or chest radiation.

Environmental exposure: Long-term contact with carcinogenic substances.

Patient undergoing chest radiotherapy, illustrating that prior chest radiation increases the risk of developing breast cancer
A history of chest radiation increases the risk of developing breast cancer.

Diagnosis

Physicians perform a comprehensive breast exam to detect abnormalities. Key tests include:

  • Mammography: X-ray imaging for screening and diagnosis.
  • Breast ultrasound: Uses sound waves to evaluate internal structures.
  • Breast MRI: Provides high-resolution imaging of soft tissue for improved accuracy.
  • Biopsy: Sampling of tissue or fluid to confirm malignancy.
  • Genetic blood testing: Detects mutations associated with breast cancer.
Doctor reviewing a mammogram image to detect abnormalities in breast tissue for screening and diagnosis
Mammography provides detailed images of breast tissue for both screening and diagnostic purposes.

Treatment

Therapy depends on stage, age, health status, and metastasis:

Surgery:

Lumpectomy: Removal of tumors with surrounding normal tissue, often preferred for lesions <5 cm.

Mastectomy: Complete removal of breast tissue with lymph node dissection to reduce recurrence risk.

Possible side effects: Cosmetic changes, pain, scarring, infection, or swelling.

Radiotherapy:

High-dose radiation to destroy residual cancer cells after surgery.

Side effects: Pain, swelling, skin redness, fatigue, sore throat, or lymphedema.

Chemotherapy:

Systemic therapy targeting rapidly dividing cancer cells, administered before or after surgery.

Side effects: Hair loss, nausea, diarrhea, increased infection and bleeding risk.

Surgeons performing tumor removal surgery for multifocal breast cancer
Phẫu thuật cắt bỏ khối u là phương pháp điều trị chính cho ung thư vú đa ổ.

Lifestyle and Prevention

Healthy Habits:

Regular follow-up: Adhere to checkups and monitoring schedules; report new symptoms promptly.

Physical activity: Gentle exercise such as yoga, walking, or swimming can boost well-being. Consult your physician before starting.

Mental health: Join cancer support groups and continue enjoyable activities to reduce stress.

Skin care: Avoid direct sun on irradiated skin; use gentle, non-irritating products.

Nutrition:

Recommended:

  • Leafy greens, tomatoes, broccoli, and berries rich in antioxidants;
  • Protein sources such as fish, eggs, tofu, and chicken to support energy and recovery;
  • Whole grains like brown rice and oats for fiber;
  • Hydration: 2–3 liters of water daily, plus green tea or unsweetened juices.

Limit:

  • Processed, high-fat, or sugary foods;
  • Alcohol and caffeine.
Doctor performing breast ultrasound for follow-up examination in a patient with multifocal breast cancer
Follow-up breast ultrasound as directed by the doctor helps monitor the treatment progress of multifocal breast cancer.

Prevention:

Screening: Mammograms, ultrasound, or genetic testing if high-risk.

Maintain healthy weight: Avoid overweight/obesity.

No smoking; limit alcohol: Both linked to higher breast cancer risk.

Balanced diet: Prioritize vegetables and fruits, limit processed food.

Exercise regularly: At least 30 minutes per day.

Reduce carcinogen exposure: Avoid harmful chemicals at work or in the environment.

Manage comorbidities: Control diabetes, hypertension, and hormone-related disorders.

 

Previous ArticleStage 1 Colon Cancer
Next Article Connective Tissue Cancer
Andrew Parker, MD
  • Website

Dr. Andrew Parker is a board-certified internal medicine physician with over 10 years of clinical experience. He earned his medical degree from the University of California, San Francisco (UCSF), and has worked at leading hospitals including St. Mary’s Medical Center. Dr. Parker specializes in patient education and digital health communication. He now focuses on creating clear, accessible, and evidence-based medical content for the public.

Related Posts

Chondrosarcom

September 20, 2025

Angiosarcoma

September 20, 2025

Connective Tissue Cancer

September 19, 2025
Don't Miss
Cancer

Chondrosarcom

What is chondrosarcoma? Symptoms, causes, diagnosis and treatment Chondrosarcoma is a type of bone cancer…

Angiosarcoma

Cancer

Connective Tissue Cancer

Cancer

Multifocal Breast Cancer

Cancer
Our Picks

Chondrosarcom

Cancer

Angiosarcoma

Cancer

Connective Tissue Cancer

Cancer

Multifocal Breast Cancer

Cancer
About Us
About Us

GoodMedToday is a global health blog providing trustworthy, reader-friendly information on diseases, medications, healthy living, and medical therapies. We help you make informed health decisions with content based on reputable medical sources.

Contact Us: contact@goodmedtoday.com
Contact: +1-320-0123-451

Our Picks
New Comments

    Type above and press Enter to search. Press Esc to cancel.